{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:11:51Z","timestamp":1793067111076,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jacc.2024.01.029","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T14:44:45Z","timestamp":1711377885000},"page":"1243-1252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Enhanced Decongestive Therapy in Patients With Acute Heart\u00a0Failure"],"prefix":"10.1016","volume":"83","author":[{"given":"Gad","family":"Cotter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Davison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidiu","family":"Chioncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2024.01.029_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_77_19","article-title":"Congestive heart failure: a history","volume":"20","author":"Hajar","year":"2019","journal-title":"Heart Views"},{"key":"10.1016\/j.jacc.2024.01.029_bib2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","article-title":"Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial","volume":"34","author":"Ambrosy","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.01.029_bib3","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","article-title":"Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure","volume":"363","author":"Massie","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.jacc.2024.01.029_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.01.029_bib5","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.01.029_bib6","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.01.029_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.01.029_bib8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","article-title":"Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy","volume":"12","author":"Ter Maaten","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2024.01.029_bib9","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/ehf2.13372","article-title":"Spot urine sodium in acute heart failure: differences in prognostic value on admission and discharge","volume":"8","author":"Biegus","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2024.01.029_bib10","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/s41591-023-02532-z","article-title":"Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial","volume":"29","author":"ter Maaten","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2024.01.029_bib11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in Acute Decompensated Heart\u00a0Failure with Volume Overload","volume":"387","author":"Mullens","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.jacc.2024.01.029_bib12","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/ejhf.2863","article-title":"Sodium and potassium changes during decongestion with acetazolamide-A pre-specified analysis from the ADVOR trial","volume":"25","author":"Dhont","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"37","key":"10.1016\/j.jacc.2024.01.029_bib13","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1093\/eurheartj\/ehad557","article-title":"Renal function and decongestion with acetazolamide in acute decompensated heart failure: the ADVOR trial","volume":"44","author":"Meekers","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.01.029_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/eurheartj\/ehac689","article-title":"Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial","volume":"44","author":"Trull\u00e0s","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.01.029_bib15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurjhf\/hfp108","article-title":"Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart\u00a0Failure (COACH)","volume":"11","author":"Damman","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.01.029_bib16","first-page":"890","article-title":"Association of early blood pressure decrease and renal function with prognosis in acute heart failure","volume":"9","author":"Matsue","year":"2021","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2024.01.029_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00392-020-01753-3","article-title":"Serum potassium dynamics during acute heart failure hospitalization","volume":"111","author":"Caravaca Perez","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2024.01.029_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1388-9842(02)00017-X","article-title":"Acute heart failure: a novel approach to its pathogenesis and treatment","volume":"4","author":"Cotter","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.01.029_bib19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/ejhf.2754","article-title":"Targeting the \u201cvulnerable\u201d period - first 3-6\u00a0months after an acute heart failure admission - the light gets brighter","volume":"25","author":"Cotter","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.01.029_bib20","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.01.029_bib21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2024.01.029_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.01.029_bib23","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1161\/CIRCULATIONAHA.118.039331","article-title":"Clinical outcomes in patients with acute decompensated heart failure randomly assigned to sacubitril\/valsartan or enalapril in the PIONEER-HF Trial","volume":"139","author":"Morrow","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.01.029_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2023.04.019","article-title":"Angiotensin-neprilysin inhibition in patients with mildly reduced or preserved ejection fraction and worsening heart failure","volume":"82","author":"Mentz","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.jacc.2024.01.029_bib25","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/ejhf.3074","article-title":"Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure","volume":"25","author":"ter Maaten","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.01.029_bib26","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/eurheartj\/ehad341","article-title":"Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics","volume":"44","author":"Yeoh","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.01.029_bib27","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/ejhf.2664","article-title":"Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart\u00a0Failure Association, European Society of Cardiology","volume":"24","author":"N\u00fa\u00f1ez","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.01.029_bib28","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/ejhf.890","article-title":"Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart\u00a0Failure Long-Term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.01.029_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejheart.2008.01.007","article-title":"Fluid overload in acute heart failure\u2014re-distribution and other mechanisms beyond fluid accumulation","volume":"10","author":"Cotter","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.01.029_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.15420\/CFR.2015.01.01.38","article-title":"Pulmonary oedema-therapeutic targets","volume":"1","author":"Chioncel","year":"2015","journal-title":"Card Fail Rev"},{"issue":"17","key":"10.1016\/j.jacc.2024.01.029_bib31","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacc.2024.01.029_bib32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.jacc.2024.01.029_bib33","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2016.07.763","article-title":"Effect of aldosterone antagonism on exercise tolerance in heart failure with preserved ejection fraction","volume":"68","author":"Kosmala","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jacc.2024.01.029_bib34","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","article-title":"for the MOCHA Investigators. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure","volume":"94","author":"Bristow","year":"1996","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacc.2024.01.029_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.106.666016","article-title":"Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial","volume":"116","author":"Colucci","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacc.2024.01.029_bib36","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0735-1097(02)02063-6","article-title":"Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study","volume":"40","author":"Wong","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jacc.2024.01.029_bib37","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1253\/circrep.CR-19-0018","article-title":"Effects of sodium-glucose cotransporter 2 inhibitor on vascular endothelial and diastolic function in heart failure with preserved ejection fraction - novel prospective cohort study","volume":"1","author":"Sakai","year":"2019","journal-title":"Circ Rep"},{"issue":"5","key":"10.1016\/j.jacc.2024.01.029_bib38","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15209","article-title":"Impact of angiotensin receptor-neprilysin inhibition on vascular function in heart failure with reduced ejection fraction: a pilot study","volume":"10","author":"Nathaniel","year":"2022","journal-title":"Physiol Rep"},{"key":"10.1016\/j.jacc.2024.01.029_bib39","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/0002-9149(82)90376-9","article-title":"Effects of captopril on prostaglandin and natriuresis in patients with essential hypertension","volume":"49","author":"Hornych","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.01.029_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ejhf.2703","article-title":"Sacubitril\/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON-HF trial","volume":"25","author":"Chatur","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.01.029_bib41","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/01.CIR.102.19.2325","article-title":"Striking increase of natriuresis by low-dose spironolactone in congestive heart failure only in combination with ACE inhibition: mechanistic evidence to support RALES","volume":"102","author":"Bauersachs","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.01.029_bib42","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.120.047077","article-title":"Dapagliflozin and diuretic use in patients with heart failure and reduced ejection fraction in DAPA-HF","volume":"142","author":"Jackson","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.01.029_bib43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ejhf.1402","article-title":"Reduced loop diuretic use in patients taking sacubitril\/valsartan compared with enalapril: the PARADIGM-HF trial","volume":"21","author":"Vardeny","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.01.029_bib44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","article-title":"Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial","volume":"44","author":"Biegus","year":"2023","journal-title":"Eur Heart J"},{"issue":"Suppl G","key":"10.1016\/j.jacc.2024.01.029_bib45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/eurheartj\/13.suppl_G.28","article-title":"Neurohormonal consequences of diuretics in different cardiovascular syndromes","volume":"13","author":"Burnier","year":"1992","journal-title":"Eur Heart J"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724002535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724002535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T18:32:31Z","timestamp":1744223551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109724002535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":45,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0735109724002535"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2024.01.029","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced Decongestive Therapy in Patients With Acute Heart\u00a0Failure","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2024.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}